Edition:
United States

Express Scripts Holding Co (ESRX.O)

ESRX.O on Nasdaq

61.62USD
22 Aug 2017
Change (% chg)

$1.29 (+2.14%)
Prev Close
$60.33
Open
$60.52
Day's High
$61.78
Day's Low
$60.45
Volume
2,915,257
Avg. Vol
4,218,110
52-wk High
$77.61
52-wk Low
$57.80

Select another date:

Wed, Aug 2 2017

Express Scripts wins dismissal of lawsuit over Anthem ties

NEW YORK A federal judge has dismissed a lawsuit in which Express Scripts Holding Co shareholders accused the pharmacy benefits manager of inflating its share price by hiding its deteriorating relationship with its largest customer, Anthem Inc.

Express Scripts wins dismissal of lawsuit over Anthem ties

NEW YORK A federal judge has dismissed a lawsuit in which Express Scripts Holding Co shareholders accused the pharmacy benefits manager of inflating its share price by hiding its deteriorating relationship with its largest customer, Anthem Inc .

Express Scripts wins dismissal of lawsuit over Anthem ties

NEW YORK, Aug 2 A federal judge has dismissed a lawsuit in which Express Scripts Holding Co shareholders accused the pharmacy benefits manager of inflating its share price by hiding its deteriorating relationship with its largest customer, Anthem Inc.

Express Scripts to cover Mylan's EpiPen, exclude rivals

NEW YORK Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker Mylan Inc's versions of the EpiPen lifesaving allergy treatment over the allergy auto-injectors of other companies.

Express Scripts to cover Mylan's EpiPen, exclude rivals

NEW YORK Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker Mylan Inc's versions of the EpiPen lifesaving allergy treatment over the allergy auto-injectors of other companies.

Express Scripts to cover Mylan's EpiPen, exclude rivals

NEW YORK, July 31 Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker Mylan Inc's versions of the EpiPen lifesaving allergy treatment over the allergy auto-injectors of other companies.

Express Scripts bearish on new Anthem contract

July 25 Pharmacy benefit manager Express Scripts Holding Co said on Tuesday that a new contract with biggest customer Anthem Inc would be on terms significantly less favorable for the company.

BRIEF-Express Scripts Q2 earnings per share $1.37

* Q2 earnings per share view $1.71 -- Thomson Reuters I/B/E/S

BRIEF-Jazz Pharmaceuticals says on June 28, its unit entered into pharmacy master services agreement with Express Scripts specialty distribution services

* Jazz Pharmaceuticals says on June 28, its unit entered into a pharmacy master services agreement with express scripts specialty distribution services

BRIEF-Express Scripts elects Kathleen Mazzarella to board of directors

* Express Scripts elects Kathleen M. Mazzarella to board of directors Source text for Eikon: Further company coverage:

Select another date: